NEURAXIS, INC. Financing Receivable, before Allowance for Credit Loss, Current
NEURAXIS, INC. (NRXS) had Financing Receivable, before Allowance for Credit Loss, Current of $1.01 million as of 2023-06-30, per its 10-Q filed 2023-09-22.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:NotesAndLoansReceivableGrossCurrent · last filed 2023-09-22
- 2023-06-30: Financing Receivable, before Allowance for Credit Loss, Current $1.01M.
- 2022-12-31: Financing Receivable, before Allowance for Credit Loss, Current $1.01M.
| Period end | Financing Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2023-06-30 | $1.01M 10-Q · filed 2023-09-22 |
| 2022-12-31 | $1.01M 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |